Related Experiment Video
Updated: Jan 1, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
G-protein-coupled receptor kinase 2 safeguards epithelial phenotype in head and neck squamous cell carcinomas
Julia Palacios-García1,2, María Sanz-Flores1,2, Alejandro Asensio1,2
1Departamento de Biología Molecular and Centro de Biología Molecular "Severo Ochoa" (UAM-CSIC), Madrid, Spain.
Abstract:
Head and neck squamous cell carcinoma (HNSCC) arises from the mucosal lining of the upper aerodigestive tract and display few treatment options in advanced stages. Despite increased knowledge of HNSCC molecular biology, the identification of new players involved in triggering HNSCC recurrence and metastatic disease is needed. We uncover that G-protein-coupled receptor kinase-2 (GRK2) expression is reduced in undifferentiated, high-grade human HNSCC tumors, whereas its silencing in model human HNSCC cells is sufficient to trigger epithelial-to-mesenchymal transition (EMT) phenotypic features, an EMT-like transcriptional program and enhanced lymph node colonization from orthotopic tongue tumors in mice. Conversely, enhancing GRK2 expression counteracts mesenchymal cells traits by mechanisms involving phosphorylation and decreased functionality of the key EMT inducer Snail1. Our results suggest that GRK2 safeguards the epithelial phenotype, whereas its downregulation contributes to the activation of EMT programs in HNSCC.
Insights
Reduced G-protein-coupled receptor kinase-2 (GRK2) expression in head and neck squamous cell carcinoma (HNSCC) promotes tumor cell invasion and metastasis. Restoring GRK2 levels can suppress these aggressive traits by inhibiting key cancer-promoting pathways.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Head and neck squamous cell carcinoma (HNSCC) presents limited treatment options for advanced stages.
- Understanding molecular drivers of HNSCC recurrence and metastasis is crucial for developing new therapies.
Purpose of the Study:
- To investigate the role of G-protein-coupled receptor kinase-2 (GRK2) in HNSCC progression.
- To determine if GRK2 downregulation contributes to epithelial-to-mesenchymal transition (EMT) and metastasis in HNSCC.
Main Methods:
- Analysis of GRK2 expression in human HNSCC tumors.
- Silencing and overexpression of GRK2 in HNSCC cell lines.
- Assessment of EMT markers and transcriptional programs.
- Evaluation of lymph node colonization in mouse models.
- Investigation of GRK2's effect on Snail1 phosphorylation and activity.
Main Results:
- GRK2 expression is decreased in undifferentiated, high-grade HNSCC.
- GRK2 silencing in HNSCC cells induces EMT features and enhances lymph node metastasis in vivo.
- Increased GRK2 expression reverses mesenchymal traits and reduces Snail1 functionality.
- GRK2 phosphorylation and inactivation of Snail1 are key mechanisms.
Conclusions:
- GRK2 acts as a tumor suppressor by maintaining the epithelial phenotype in HNSCC.
- Downregulation of GRK2 facilitates EMT activation and promotes HNSCC metastasis.
- Targeting GRK2 may offer a therapeutic strategy for advanced HNSCC.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Mitogens and the Cell Cycle
The Ras Gene
Ras is a...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:

